BioRem Statistics

Total Valuation

BioRem has a market cap or net worth of CAD 53.24 million. The enterprise value is 44.57 million.

Market Cap	53.24M
Enterprise Value	44.57M

Important Dates

The last earnings date was Friday, April 17, 2026.

Earnings Date	Apr 17, 2026
Ex-Dividend Date	n/a

Share Statistics

BioRem has 16.13 million shares outstanding. The number of shares has decreased by -0.40% in one year.

Current Share Class	16.13M
Shares Outstanding	16.13M
Shares Change (YoY)	-0.40%
Shares Change (QoQ)	-10.19%
Owned by Insiders (%)	2.00%
Owned by Institutions (%)	n/a
Float	15.81M

Valuation Ratios

The trailing PE ratio is 12.69.

PE Ratio	12.69
Forward PE	n/a
PS Ratio	1.26
PB Ratio	3.57
P/TBV Ratio	3.57
P/FCF Ratio	7.32
P/OCF Ratio	6.97
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.33, with an EV/FCF ratio of 6.13.

EV / Earnings	9.25
EV / Sales	1.05
EV / EBITDA	6.33
EV / EBIT	6.78
EV / FCF	6.13

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.19.

Current Ratio	1.85
Quick Ratio	1.62
Debt / Equity	0.19
Debt / EBITDA	0.40
Debt / FCF	0.39
Interest Coverage	40.59

Financial Efficiency

Return on equity (ROE) is 37.70% and return on invested capital (ROIC) is 75.92%.

Return on Equity (ROE)	37.70%
Return on Assets (ROA)	13.24%
Return on Invested Capital (ROIC)	75.92%
Return on Capital Employed (ROCE)	38.49%
Weighted Average Cost of Capital (WACC)	8.00%
Revenue Per Employee	1.25M
Profits Per Employee	141,665
Employee Count	34
Asset Turnover	1.36
Inventory Turnover	13.85

Taxes

In the past 12 months, BioRem has paid 1.51 million in taxes.

Income Tax	1.51M
Effective Tax Rate	23.89%

Stock Price Statistics

The stock price has increased by +66.67% in the last 52 weeks. The beta is 0.72, so BioRem's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+66.67%
50-Day Moving Average	2.61
200-Day Moving Average	2.35
Relative Strength Index (RSI)	82.34
Average Volume (20 Days)	47,133

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioRem had revenue of CAD 42.36 million and earned 4.82 million in profits. Earnings per share was 0.26.

Revenue	42.36M
Gross Profit	12.77M
Operating Income	6.57M
Pretax Income	6.33M
Net Income	4.82M
EBITDA	6.91M
EBIT	6.57M
Earnings Per Share (EPS)	0.26

Full Income Statement

Balance Sheet

The company has 11.50 million in cash and 2.83 million in debt, giving a net cash position of 8.67 million or 0.54 per share.

Cash & Cash Equivalents	11.50M
Total Debt	2.83M
Net Cash	8.67M
Net Cash Per Share	0.54
Equity (Book Value)	14.93M
Book Value Per Share	0.93
Working Capital	14.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.64 million and capital expenditures -367,826, giving a free cash flow of 7.27 million.

Operating Cash Flow	7.64M
Capital Expenditures	-367,826
Depreciation & Amortization	334,539
Net Borrowing	-682,438
Free Cash Flow	7.27M
FCF Per Share	0.45

Full Cash Flow Statement

Margins

Gross margin is 30.14%, with operating and profit margins of 15.52% and 11.37%.

Gross Margin	30.14%
Operating Margin	15.52%
Pretax Margin	14.94%
Profit Margin	11.37%
EBITDA Margin	16.31%
EBIT Margin	15.52%
FCF Margin	17.17%

Dividends & Yields

BioRem does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.40%
Shareholder Yield	0.40%
Earnings Yield	9.05%
FCF Yield	13.66%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioRem has an Altman Z-Score of 3.84 and a Piotroski F-Score of 7.

Altman Z-Score	3.84
Piotroski F-Score	7